Strategies for coordinating a national agenda on the implementation of immunobiological drug outpatient infusion center in the Brazilian Unified Health System
Jornal Brasileiro de Políticas Farmacêuticas · 2025
DOI: 10.63433/jbpf.2025.6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jornal Brasileiro de Políticas Farmacêuticas, 2025. Verfasst von Carla Lemos Gottgtroy und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Immunobiological drugs were introduced into the Brazilian Unified Health System (SUS) in 2002, and their incorporation has grown significantly since then. Although no national policy regulates the care of patients who use them, these drugs are part of the Specialized Component of Pharmaceutical Services (CEAF). In several regions, CEAF-affiliated pharmacies or dispensing centers deliver non-oncological immunobiologics directly to patients without providing the necessary infusion care, raising concerns about patient safety and the potential misuse of public resources.
Objective
To evaluate how states structure care for patients who use non-oncological immunobiological drugs in the SUS and to promote collaboration in creating a national agenda for the implementation of public outpatient infusion centers(CTAs).
Methods
The methodology involved a multi-step process. The first stage, a survey, was completed by public institutions with established CTA services, covering areas such as Health Network Management, People Management, Administrative Management, and Care Management. The second stage included an in-person workshop at Bio-Manguinhos/Fiocruz, where successful experiences were discussed. Finally, the third stage involved presenting the findings in a report, followed by discussions at state Pharmaceutical Assistance conferences to advance the agenda.
Results
The findings from this experience highlight several successful models implemented in different states, revealing common elements that can inform the development of CTAs within the SUS. The need for discussion and adaptation to regional diversities and specific contextual factors, however, remains a significant challenge.
Conclusion
Successful initiatives for access to immunobiological drugs through structured CTAs represent an opportunity to promote the rational use of these drugs, with the potential to improve access and cost-effectiveness.
Zitieren
APA
Gottgtroy, C. L., Marques, A. D. M., Catão, T. P., Pinto, C. R., & Varela, J. D. N. E. S. (2025). Strategies for coordinating a national agenda on the implementation of immunobiological drug outpatient infusion center in the Brazilian Unified Health System. Jornal Brasileiro de Políticas Farmacêuticas. https://doi.org/10.63433/jbpf.2025.6
Vancouver
Gottgtroy CL, Marques ADM, Catão TP, Pinto CR, Varela JDNES. Strategies for coordinating a national agenda on the implementation of immunobiological drug outpatient infusion center in the Brazilian Unified Health System. Jornal Brasileiro de Políticas Farmacêuticas. 2025. doi:10.63433/jbpf.2025.6
BibTeX
@article{Gottgtroy2025,
author = {Gottgtroy, Carla Lemos and Marques, Amanda de Miranda and Catão, Thaís Pereira and Pinto, Charleston Ribeiro and Varela, Julianna do Nascimento e Silva},
title = {Strategies for coordinating a national agenda on the implementation of immunobiological drug outpatient infusion center in the Brazilian Unified Health System},
journal = {Jornal Brasileiro de Políticas Farmacêuticas},
year = {2025},
doi = {10.63433/jbpf.2025.6}
}
EUVIMED